417 related articles for article (PubMed ID: 32834893)
21. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System.
Costa LB; Perez LG; Palmeira VA; Macedo E Cordeiro T; Ribeiro VT; Lanza K; Simões E Silva AC
Front Cell Dev Biol; 2020; 8():559841. PubMed ID: 33042994
[TBL] [Abstract][Full Text] [Related]
22. Mutant plasminogen in hereditary angioedema is bypassing FXII/kallikrein to generate bradykinin.
Hintze S; Möhl BS; Beyerl J; Wulff K; Wieser A; Bork K; Meinke P
Front Physiol; 2022; 13():1090732. PubMed ID: 36685169
[TBL] [Abstract][Full Text] [Related]
23. Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema.
Loffredo S; Bova M; Suffritti C; Borriello F; Zanichelli A; Petraroli A; Varricchi G; Triggiani M; Cicardi M; Marone G
Allergy; 2016 Jul; 71(7):989-96. PubMed ID: 26873113
[TBL] [Abstract][Full Text] [Related]
24. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
Zanichelli A; Wu MA; Andreoli A; Mansi M; Cicardi M
Expert Opin Drug Saf; 2015; 14(11):1725-36. PubMed ID: 26429506
[TBL] [Abstract][Full Text] [Related]
25. The complex alteration in the network of IL-17-type cytokines in patients with hereditary angioedema.
Arcoleo F; Lo Pizzo M; Misiano G; Milano S; Romano GC; Muggeo V; Cillari E
Clin Exp Med; 2018 Aug; 18(3):355-361. PubMed ID: 29623491
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 infection and smoking: What is the association? A brief review.
Gupta I; Sohail MU; Elzawawi KE; Amarah AH; Vranic S; Al-Asmakh M; Al Moustafa AE
Comput Struct Biotechnol J; 2021; 19():1654-1660. PubMed ID: 33777332
[TBL] [Abstract][Full Text] [Related]
27. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
Kaplan AP; Joseph K
Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
[TBL] [Abstract][Full Text] [Related]
28. [Acquired C1 esterase inhibitor deficiency via bradykinin-mediated angioedema: Four cases].
Jacquin-Porretaz C; Castelain F; Daguindau E; Seilles E; Nardin C; Aubin F; Pelletier F
Ann Dermatol Venereol; 2018 Oct; 145(10):598-602. PubMed ID: 29673745
[TBL] [Abstract][Full Text] [Related]
29. Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19.
Chatterjee SK; Saha S; Munoz MNM
Front Mol Biosci; 2020; 7():196. PubMed ID: 32850977
[TBL] [Abstract][Full Text] [Related]
30. Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.
Bouillet L; Boccon-Gibod I; Launay D; Gompel A; Kanny G; Fabien V; Fain O;
Immun Inflamm Dis; 2017 Mar; 5(1):29-36. PubMed ID: 28250922
[TBL] [Abstract][Full Text] [Related]
31. The role of ficolins and MASPs in hereditary angioedema due to C1-inhibitor deficiency.
Csuka D; Munthe-Fog L; Skjoedt MO; Kocsis A; Zotter Z; Gál P; Varga L; Farkas H; Füst G; Garred P
Mol Immunol; 2013 Jul; 54(3-4):271-7. PubMed ID: 23318225
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies.
Aygören-Pürsün E; Magerl M; Maetzel A; Maurer M
Orphanet J Rare Dis; 2018 May; 13(1):73. PubMed ID: 29728119
[TBL] [Abstract][Full Text] [Related]
33. Acquired and hereditary forms of recurrent angioedema: Update of treatment.
Bork K
Allergol Select; 2018; 2(1):121-131. PubMed ID: 31826031
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting.
Craig TJ; Bernstein JA; Farkas H; Bouillet L; Boccon-Gibod I
Int Arch Allergy Immunol; 2014; 165(2):119-27. PubMed ID: 25401373
[TBL] [Abstract][Full Text] [Related]
35. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
Sabharwal G; Craig T
Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442
[TBL] [Abstract][Full Text] [Related]
36. The bradykinin-forming cascade and its role in hereditary angioedema.
Kaplan AP; Joseph K
Ann Allergy Asthma Immunol; 2010 Mar; 104(3):193-204. PubMed ID: 20377108
[TBL] [Abstract][Full Text] [Related]
37. Increased thromboinflammatory load in hereditary angioedema.
Gramstad OR; Schjalm C; Mollnes TE; Nielsen EW
Clin Exp Immunol; 2023 Dec; 214(2):170-181. PubMed ID: 37561062
[TBL] [Abstract][Full Text] [Related]
38. Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema.
Deroux A; Boccon-Gibod I; Fain O; Pralong P; Ollivier Y; Pagnier A; Djenouhat K; Du-Thanh A; Gompel A; Faisant C; Launay D; Bouillet L
Clin Exp Immunol; 2016 Sep; 185(3):332-7. PubMed ID: 27271546
[TBL] [Abstract][Full Text] [Related]
39. Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.
Longhurst HJ; Zanichelli A; Caballero T; Bouillet L; Aberer W; Maurer M; Fain O; Fabien V; Andresen I;
Clin Exp Immunol; 2017 Apr; 188(1):148-153. PubMed ID: 27936514
[TBL] [Abstract][Full Text] [Related]
40. Novel Vasoregulatory Aspects of Hereditary Angioedema: the Role of Arginine Vasopressin, Adrenomedullin and Endothelin-1.
Kajdácsi E; Jani PK; Csuka D; Varga L; Prohászka Z; Farkas H; Cervenak L
J Clin Immunol; 2016 Feb; 36(2):160-70. PubMed ID: 26873707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
